Hm Payson & CO Astrazeneca PLC Transaction History
Hm Payson & CO
- $5.6 Billion
- Q1 2025
A detailed history of Hm Payson & CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Hm Payson & CO holds 55,333 shares of AZN stock, worth $3.97 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
55,333
Previous 5,561
895.02%
Holding current value
$3.97 Million
Previous $364,000
1017.03%
% of portfolio
0.07%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
507MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.1 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.92 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.56 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.29 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.25 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...